United Services Automobile Association Reata Pharmaceuticals Inc Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$71.26 - $95.75 $305,491 - $410,480	-4,287 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$77.72 - $94.35 $13,212 - $16,039	-170 Reduced 3.81%	4,287 $404,000
Q1 2019 May 13, 2019	SELL	$51.9 - $101.79 $778 - $1,526	-15 Reduced 0.34%	4,457 $381,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $62,559 - $98,072	1,283 Added 40.23%	4,472 $251,000
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $113,655 - $293,579	3,189 New	3,189 $261,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.